Overall Survival Benefit with Tebentafusp in Metastatic Uveal MelanomaPaul Nathan, Sophie Piperno‐Neumann, Josep M. Piulats et al.|New England Journal of Medicine|2021Cited by 869
PD-1 Blockade in Anaplastic Thyroid CarcinomaJaume Capdevila, Matthew H. Taylor, Lori J. Wirth et al.|Journal of Clinical Oncology|2020Cited by 349
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapySacha Gnjatic, Lisa H. Butterfield, Vincenzo Bronte et al.|Journal for ImmunoTherapy of Cancer|2017Cited by 239
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trialDavid S. Hong, Marcus O. Butler|Nature Medicine|2023Cited by 185
Response to Immune Checkpoint Inhibition in Two Patients with Alveolar Soft-Part SarcomaJeremy Lewin, Albiruni R. Abdul Razak, Scott Davidson et al.|Cancer Immunology Research|2018Cited by 53